Newsroom | 5158 results

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at three upcoming investor conferences: TD Cowen's 46th Annual Health Care Conference Fireside Chat: Monday, March 2, 2026 at 11:10 a.m. Eastern Time in Boston, MA The Citizens Life Sciences Conference Fireside Chat: Wednesday, March 11, 2026 at 1:05 p.m. Eastern Time in Miami Beach, FL Live webcasts will be accessible on the company’s website, acadia.com, under the investors section...

SAN RAMON, Calif.--(BUSINESS WIRE)--MediKarma, the AI-driven platform that unifies and activates patient data to drive proactive care, today announced it has successfully completed the acquisition of Nanell, a specialized digital solution focused on the pregnancy journey, from Niterra Co., Ltd (Headquarters: Nagoya, Japan). The acquisition is set to integrate Nanell's intellectual property, product assets and operations directly into MediKarma’s platform, strengthening its offering in Women’s H...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company’s management team will participate in the following upcoming investor conferences: TD Cowen 46th Annual Healthcare Conference, March 2-5, 2026 Format: Fireside chat and one-on-one meetings Presentation Date & Time: March 3, 2026, 1:50...

ROME & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience (“Quiver”), a discovery technology and therapeutics company advancing programs for the treatment of central nervous system (CNS) disorders, announced today that they have entered into a collaboration and licensing agreement to advance novel therapeutics for genetic epilepsies. The collaboration brings together Quiver’s unique drug discovery capabilities, data assets,...

ROMA, ITALIA e CAMBRIDGE, MASSACHUSETTS--(BUSINESS WIRE)--Angelini Pharma, azienda farmaceutica parte del Gruppo Angelini Industries e Quiver Bioscience (“Quiver”), azienda specializzata in tecnologie per la scoperta e lo sviluppo di terapie innovative per il trattamento dei disturbi del sistema nervoso centrale (CNS), hanno annunciato oggi la sigla di collaborazione per la ricerca, lo sviluppo e la commercializzazione di nuove terapie per le epilessie genetiche. La collaborazione integra le co...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the fourth quarter of 2025 after market close on Tuesday, March 3, 2026. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). Investors interested in listening to the conference call may do so by accessin...

ALAMEDA, Calif. & GENEVA--(BUSINESS WIRE)--Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural data company utilizing ultra-soft interfaces to achieve full-cortical coverage powering a foundation AI model of the brain, have partnered to grant Neurosoft access to Science’s full stack of world-class clinical-grade neural recording tools, known as the Science BCI Ecosystem. Science Ecosystem partn...

BOSTON--(BUSINESS WIRE)--Seaport presents new meta-analysis examining the impact of clinical trial design factors on placebo response in generalized anxiety disorder trials...

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results for the full year ended December 31, 2025, and discuss recent business updates. Listeners...

NORTH BETHESDA, Md.--(BUSINESS WIRE)--New research from an FNIH Biomarkers Consortium study shows a blood test can predict the onset of Alzheimer's symptoms within 3 to 4 years....